HopeStage
Back to all studies
CompletedNCT00316303

An infection-screening and referral program for people with mental health and substance-use conditions

About this titleRead the official source — NCT00316303
Medication studyAges 18–65United StatesSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
BaltimoreSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateFebruary 2006
Recruitment status
Completed
Enrollment listed in the registry
236
Sponsor
Dartmouth-Hitchcock Medical Center
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00316303
Official title
Show the full official title

The STIRR Intervention for Dually Diagnosed Clients

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Baltimore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Dartmouth-Hitchcock Medical Center, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Twinrix.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies